Get started
Author

Patience Ndidi Eschenhagen

Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
2019 · Petra Bacher, Thordis Hohnstein, et al. · Cell · 483
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
2022 · Jochen G. Mainz, Carlos Zagoya, et al. · Frontiers in Pharmacology · 80
PDF
Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function
2020 · Uta Düesberg, Julia Wosniok, et al. · Scientific Reports · 52
PDF
Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
2020 · Iris Stoler, Judith Freytag, et al. · Frontiers in Immunology · 42
PDF
ECFS standards of care on CFTR-related disorders: Identification and care of the disorders
2024 · N.J. Simmonds, K.W. Southern, et al. · Journal of Cystic Fibrosis · 39
PDF
Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients
2021 · Astrid Lewin, Elisabeth Kamal, et al. · Virulence · 32
PDF
Antigen specificity and cross-reactivity drive functionally diverse anti–Aspergillus fumigatus T cell responses in cystic fibrosis
2023 · Carsten Schwarz, Patience Eschenhagen, et al. · Journal of Clinical Investigation · 30
PDF
Emerging Fungal Threats in Cystic Fibrosis
2021 · C. Schwarz, P. Eschenhagen, et al. · Mycopathologia · 27
Clinician variability in the diagnosis and treatment of aspergillus fumigatus-related conditions in cystic fibrosis: An international survey
2021 · Gina Hong, Sameer Desai, et al. · Journal of Cystic Fibrosis · 19
Prospective Evaluation of Aspergillus fumigatus-Specific IgG in Patients With Cystic Fibrosis
2021 · Patience Eschenhagen, Claudia Grehn, et al. · Frontiers in Cellular and Infection Microbiology · 17
PDF
Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy
2023 · Patience N. Eschenhagen, Petra Bacher, et al. · Frontiers in Pharmacology · 14
PDF
Clinical impact of levofloxacin inhalation solution in cystic fibrosis patients in a real-world setting
2021 · Carsten Schwarz, Claudia Grehn, et al. · Journal of Cystic Fibrosis · 14
Urban Life as Risk Factor for Aspergillosis
2020 · Claudia Grehn, Patience Eschenhagen, et al. · Frontiers in Cellular and Infection Microbiology · 10
PDF
Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
2021 · Claudia Grehn, Patience Eschenhagen, et al. · Frontiers in Cellular and Infection Microbiology · 9
PDF
Pulmonary Aspergillosis in People with Cystic Fibrosis
2024 · C. Schwarz, P.N. Eschenhagen, et al. · Seminars in Respiratory and Critical Care Medicine · 7
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire
2023 · Jochen G. Mainz, Anton Barucha, et al. · Frontiers in Pharmacology · 7
PDF
S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Pseudomonas aeruginosa
2024 · Carsten Schwarz, Jutta Bend, et al. · Pneumologie · 5
PDF
Patienten mit zystischer Fibrose werden erwachsen: Therapeutische Hoffnungen und Enttäuschungen
2019 · Patience Eschenhagen, Carsten Schwarz · Der Internist · 5
Validation of the CFAbd-Score.kidⒸ, a Novel gastrointestinal patient reported outcome measure, specific for children with cystic fibrosis
2025 · Pauline Sadrieh, Lilith Bechinger, et al. · Journal of Cystic Fibrosis · 3
PDF
Antibiotic Therapy for Pulmonary Exacerbations in Cystic Fibrosis—A Single-Centre Prospective Observational Study
2023 · Carsten Schwarz, Eliana Wimmer, et al. · Antibiotics · 3
PDF
EPS3.05 N-chlorotaurine is a very promising antiseptic treatment option for multiresistant bacteria, fungi and for viruses including SARS-CoV-2
2021 · C. Schwarz, M. Lackner, et al. · Journal of Cystic Fibrosis · 3
Prevalence and disease trajectories of pulmonary fibrosis of childhood interstitial lung disease: a register-based, multicentre observational study
2026 · Matthias Griese, Simone Reu-Hofer, et al. · The Lancet Respiratory Medicine · 2
Respiratory Fungal Infections in Cystic Fibrosis: Diagnostic and Therapeutic Challenges
2023 · C. Schwarz, J. G. Mainz, et al. · Current Fungal Infection Reports · 2
PDF
Further Genetic Unraveling of Persistent Tachypnea of Infancy
2026 · Christina K. Rapp, Katharina Mauss-Schwarzer, et al. · CHEST Journal · 1
P167 Pulmonary infections due to fungi in the era of CFTR modulator therapy
2025 · C. Schwarz, E. Romanowska, et al. · Journal of Cystic Fibrosis · 1
Works count: 61
Citation count: 911
H-index: 12
I10-index: 13
Year
Topic
Type